Target intelligence / Profile preview

Proteasome subunit alpha 2 pseudogene 3 (PSMA2P3)

Target: PSMA2P3
Molecular classification: Other (Pseudogene)

Overview

PSMA2P3 is a human pseudogene corresponding to the proteasome subunit alpha type-2 gene family. Pseudogenes are non-functional genomic DNA sequences similar to normal genes but are typically non-coding due to mutations, deletions, or lack of regulatory elements. PSMA2P3 does not encode a functional protein and does not participate in the formation or function of the 20S proteasome complex. Unlike PSMA2, which encodes one of the essential catalytic subunits of the proteasome involved in protein degradation and cellular homeostasis, PSMA2P3 serves no known biological function and is not considered a therapeutic drug target[1][7][8].

Other names: PSMA2LProteasome (prosome, macropain) subunit, alpha type, 2 pseudogene 3

Beyond the preview

Go deeper on Proteasome subunit alpha 2 pseudogene 3 (PSMA2P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proteasome subunit alpha 2 pseudogene 3 (PSMA2P3).

Explore the full profile